newsfilter
← Latest News
Business Wire·

Sierra Oncology Announces Pricing of Upsized Public Offering of Securities

Sierra Oncology, Inc. (NASDAQ:SRRA), a late-stage biopharmaceutical company dedicated to delivering targeted therapies for rare cancers, today announced the pricing of an upsized underwritten public offering of 4,074,075 shares of its common stock and,